Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.

by Zelda Euler, Marit J van Gils, Brigitte D Boeser-Nunnink, Hanneke Schuitemaker, Daniëlle van Manen
Published 2013-01-01

The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.

by Daniëlle van Manen, Maarten A N Rits, Corrine Beugeling, Karel van Dort, Hanneke Schuitemaker, Neeltje A Kootstra
Published 2008-02-01

Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs.

by Marjon Navis, Diana Edo Matas, Andrea Rachinger, Fransje A Koning, Peter van Swieten, Neeltje A Kootstra, Hanneke Schuitemaker
Published 2008-01-01

HIV-1 replication fitness of HLA-B*57/58:01 CTL escape variants is restored by the accumulation of compensatory mutations in gag.

by Esther F Gijsbers, K Anton Feenstra, Ad C van Nuenen, Marjon Navis, Jaap Heringa, Hanneke Schuitemaker, Neeltje A Kootstra
Published 2013-01-01

Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets

by Selina Khan, Nadine C. Salisch, Ana Izquierdo Gil, Satish Boedhoe, Karin Feddes-de Boer, Jan Serroyen, Hanneke Schuitemaker, Roland C. Zahn
Published 2022-11-01

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans.

by Delphine C Malherbe, Rogier W Sanders, Marit J van Gils, Byung Park, Michelle M Gomes, Hanneke Schuitemaker, Susan Barnett, Nancy L Haigwood
Published 2013-01-01

Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data.

by Art F Y Poon, Luke C Swenson, Evelien M Bunnik, Diana Edo-Matas, Hanneke Schuitemaker, Angélique B van 't Wout, P Richard Harrigan
Published 2012-01-01

Safety and immunogenicity of a new Sabin inactivated poliovirus vaccine candidate produced on the PER.C6® cell-line: a phase 1 randomized controlled trial in adults

by Isabel Leroux-Roels, Geert Leroux-Roels, Georgi Shukarev, Hanneke Schuitemaker, Conor Cahill, Richard de Rooij, Martin Struijs, Hester van Zeeburg, Jeanne-Marie Jacquet
Published 2021-05-01

The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques.

by Yufei Wang, Trevor Whittall, Durdana Rahman, Evelien M Bunnik, Robert Vaughan, Jørgen Schøller, Lesley A Bergmeier, David Montefiori, Mahavir Singh, Hanneke Schuitemaker, Thomas Lehner
Published 2012-01-01

Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.

by Nadine C Salisch, Marija Vujadinovic, Esmeralda van der Helm, Dirk Spek, Lars Vorthoren, Jan Serroyen, Harmjan Kuipers, Hanneke Schuitemaker, Roland Zahn, Jerome Custers, Jort Vellinga
Published 2017-01-01

Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users

by Zelda EULER, Tom L. VAN DEN KERKHOF, Roger D. KOUYOS, Damien C. TULLY, Todd M. ALLEN, Alexandra TRKOLA, Rogier W. SANDERS, Hanneke SCHUITEMAKER, Marit J. VAN GILS
Published 2019-04-01

Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.

by Evelien M Bunnik, Luke C Swenson, Diana Edo-Matas, Wei Huang, Winnie Dong, Arne Frantzell, Christos J Petropoulos, Eoin Coakley, Hanneke Schuitemaker, P Richard Harrigan, Angélique B van 't Wout
Published 2011-06-01

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels

by Machteld M. Tiemessen, Laura Solforosi, Liesbeth Dekking, Dominika Czapska-Casey, Jan Serroyen, Nancy J. Sullivan, Ariane Volkmann, Maria Grazia Pau, Benoit Callendret, Hanneke Schuitemaker, Kerstin Luhn, Roland Zahn, Ramon Roozendaal
Published 2022-08-01

The presence of CXCR4-using HIV-1 prior to start of antiretroviral therapy is an independent predictor of delayed viral suppression.

by Esther F Gijsbers, Ard van Sighem, Agnes M Harskamp, Matthijs R A Welkers, Frank de Wolf, Kees Brinkman, Jan M Prins, Hanneke Schuitemaker, Angélique B van 't Wout, Neeltje A Kootstra
Published 2013-01-01

Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge.

by Freek Cox, Leslie van der Fits, Peter Abbink, Rafael A Larocca, Ella van Huizen, Eirikur Saeland, Janneke Verhagen, Rebecca Peterson, Jeroen Tolboom, Baerbel Kaufmann, Hanneke Schuitemaker, Dan H Barouch, Roland Zahn
Published 2018-01-01

Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs.

by Jean-Louis Spadoni, Pierre Rucart, Sigrid Le Clerc, Daniëlle van Manen, Cédric Coulonges, Damien Ulveling, Vincent Laville, Taoufik Labib, Lieng Taing, Olivier Delaneau, Matthieu Montes, Hanneke Schuitemaker, Josselin Noirel, Jean-François Zagury
Published 2015-01-01

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.

by Leo Heyndrickx, Guillaume Stewart-Jones, Marianne Jansson, Hanneke Schuitemaker, Emma Bowles, Luigi Buonaguro, Berit Grevstad, Lasse Vinner, Katleen Vereecken, Joe Parker, Meghna Ramaswamy, Priscilla Biswas, Guido Vanham, Gabriella Scarlatti, Anders Fomsgaard, NGIN Consortium
Published 2013-01-01

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species.

by Roland Zahn, Gert Gillisen, Anna Roos, Marina Koning, Esmeralda van der Helm, Dirk Spek, Mo Weijtens, Maria Grazia Pau, Katarina Radošević, Gerrit Jan Weverling, Jerome Custers, Jort Vellinga, Hanneke Schuitemaker, Jaap Goudsmit, Ariane Rodríguez
Published 2012-01-01

Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.

by Sebastiaan M Bol, Thijs Booiman, Daniëlle van Manen, Evelien M Bunnik, Ard I van Sighem, Margit Sieberer, Brigitte Boeser-Nunnink, Frank de Wolf, Hanneke Schuitemaker, Peter Portegies, Neeltje A Kootstra, Angélique B van 't Wout
Published 2012-01-01

Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in in...

by Anna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, Delia Caparas-Yu, Astrid Greijer, Michel Duchene, Gert Scheper, Vitalija van Paassen, Mathieu Le Gars, Conor P. Cahill, Hanneke Schuitemaker, Macaya Douoguih, Jeanne-Marie Jacquet
Published 2022-11-01